An Application to Extend the Use of Rubraca for Treating Ovarian Cancer has Been Submitted to the European Medicines Agency
Free-Photos / Pixabay

An Application to Extend the Use of Rubraca for Treating Ovarian Cancer has Been Submitted to the European Medicines Agency

Clovis Oncology, Inc. has announced that they have submitted an application to the European Medicines Agency (EMA). The application is to extend the drug Rubraca’s®(rucaparib) marketing authorisation to include maintenance…

Continue Reading An Application to Extend the Use of Rubraca for Treating Ovarian Cancer has Been Submitted to the European Medicines Agency

Positive Genetic Test Results for Rare Disease Risk are not Necessarily a Cause for Alarm

According to a story from Global News, direct-to-consumer genetic tests are becoming increasingly popular. These tests can be used to learn new info about your ancient ancestors, closer relatives, and,…

Continue Reading Positive Genetic Test Results for Rare Disease Risk are not Necessarily a Cause for Alarm
Study Offers Free Screening for Cancer and BRCA Mutations for Ashkenazi Jewish Community
JoshMB / Pixabay

Study Offers Free Screening for Cancer and BRCA Mutations for Ashkenazi Jewish Community

According to a story from Jewish Community Voice, the BRCA Founder Outreach Study, which is a national, cancer-focused research study, is offering free screenings for people of Ashkenazi Jewish descent.…

Continue Reading Study Offers Free Screening for Cancer and BRCA Mutations for Ashkenazi Jewish Community
This Prostate Cancer Research May Have Implications for Breast and Ovarian Cancers Too
Source: Pixabay

This Prostate Cancer Research May Have Implications for Breast and Ovarian Cancers Too

According to News Medical, a group of researchers at Johns Hopkins and the Bloomberg-Kimmel Institute for Cancer Immunotherapy recently found encouraging results for a study involving immunotherapy to treat a…

Continue Reading This Prostate Cancer Research May Have Implications for Breast and Ovarian Cancers Too
New Computational Framework Could Increase the Effectiveness of Cancer Treatment
Source: Pixabay

New Computational Framework Could Increase the Effectiveness of Cancer Treatment

According to a story from bioengineer.org, a group of scientists working at the Columbia University Irving Medical Center (CUIMC) have managed to develop a computational model that could potentially make highly…

Continue Reading New Computational Framework Could Increase the Effectiveness of Cancer Treatment
A Woman’s Severe Breast Cancer Was Eliminated Using New Immunotherapy Approach
silviarita / Pixabay

A Woman’s Severe Breast Cancer Was Eliminated Using New Immunotherapy Approach

According to a story from The Guardian, doctors are celebrating the effectiveness of an all new, experimental immunotherapy that was able to totally eliminate a case of metastatic breast cancer…

Continue Reading A Woman’s Severe Breast Cancer Was Eliminated Using New Immunotherapy Approach
Pancreatic Cancer Patients With BRCA Mutations Could Have a New Drug on the Way
source: pixabay.com

Pancreatic Cancer Patients With BRCA Mutations Could Have a New Drug on the Way

According to a story from Worldpharmanews, a PARP inhibitor drug that is commonly used to treat ovarian cancer for patients with BRCA gene mutations could also be effective against pancreatic…

Continue Reading Pancreatic Cancer Patients With BRCA Mutations Could Have a New Drug on the Way
Some People Are Resistant to PARP Inhibitors, and Researchers Have Just Discovered Why
source: pixabay.com

Some People Are Resistant to PARP Inhibitors, and Researchers Have Just Discovered Why

According to a story from Ovarian Cancer News, a recent study has allowed scientists to determine why some people appear to be resistant to poly ADP ribose polymerase (PARP) inhibitors.…

Continue Reading Some People Are Resistant to PARP Inhibitors, and Researchers Have Just Discovered Why
A Treatment Trial Has Produced Promising Results in Patients With Myelodysplastic Syndromes
Source: Pixabay

A Treatment Trial Has Produced Promising Results in Patients With Myelodysplastic Syndromes

A press release from Aprea Theraputics has just announced the results of a Phase II clinical trial of the drug APR-246 in patients with myelodysplastic syndromes (a group of blood…

Continue Reading A Treatment Trial Has Produced Promising Results in Patients With Myelodysplastic Syndromes